Centrus Energy Corp.
LEU
$173.89
+2.01%
Centrus Energy Corp. is a leading supplier of nuclear fuel and services for the nuclear power industry, operating through Low-Enriched Uranium (LEU) and Technical Solutions segments. As the only U.S.-owned and operated enricher of high-assay low-enriched uranium (HALEU), Centrus holds a strategic monopoly in domestic HALEU production, a critical component for advanced nuclear reactors. The company is at the center of the AI-driven nuclear energy boom, with a record $3.9 billion backlog and a $900 million government contract, but faces execution risks related to its Russian contract expiration and the scaling of its HALEU operations.…
LEU
Centrus Energy Corp.
$173.89
Related headlines
Investment Opinion: Should I buy LEU Today?
Based on the analysis, I rate LEU as a Hold. The consensus analyst rating is 'Buy' with an average target of $253.25, implying 45.6% upside, but the stock's severe underperformance and high valuation warrant caution. The thesis is that Centrus has a unique strategic position in HALEU and a record backlog, but execution risks and financial instability make it a speculative hold rather than a strong buy.
Sign up to view all
LEU 12-Month Price Forecast
The AI assessment is neutral with medium confidence. While Centrus has a unique strategic position in HALEU and a record backlog, its current valuation is stretched, and its financial performance is volatile. The stock's severe underperformance relative to the market suggests that investors are already pricing in risks. To upgrade to bullish, we would need to see consistent revenue growth, improved cash flow, and successful execution of HALEU contracts. To downgrade to bearish, we would need to see a major contract loss or a dilutive capital raise.
Wall Street consensus
Most Wall Street analysts maintain a constructive view on Centrus Energy Corp.'s 12-month outlook, with a consensus price target around $248.28 and implied upside of +42.8% versus the current price.
Average Target
$248.28
0 analysts
Implied Upside
+42.8%
vs. current price
Analyst Count
—
covering this stock
Price Range
$169 - $340
Analyst target range
Analyst coverage is robust with 16 analysts providing ratings, and the consensus recommendation is a 'Buy' with a mean rating of 1.78 (where 1 is Strong Buy and 5 is Sell). The average price target is $253.25, implying a substantial 45.6% upside from the current price of $173.89. The distribution shows a bullish tilt, with 8 Buy ratings, 7 Neutral ratings, and 1 Sell rating, indicating that while the majority are positive, there is a notable contingent of cautious analysts. The high target of $340 suggests potential for a 95.5% gain, likely assuming successful HALEU commercialization and contract execution, while the low target of $180 is only 3.5% above the current price, reflecting downside risks from Russian contract expiration and execution delays. The wide spread between high and low targets ($160) indicates significant uncertainty about the company's future, consistent with its volatile revenue and the nascent HALEU market. Recent ratings actions have been predominantly neutral, with no major upgrades or downgrades in the past six months, suggesting analysts are maintaining a wait-and-see approach.
Drowning in data?
Find the real signal!
Bulls vs Bears: LEU Investment Factors
Centrus Energy presents a classic high-risk, high-reward investment. The bull case is anchored by its strategic monopoly in HALEU, a record $3.9B backlog, and strong analyst support, with an average target implying 45.6% upside. However, the bear case is equally compelling, with severe stock underperformance, elevated valuation, revenue volatility, and negative free cash flow. Currently, the bearish evidence appears stronger in the near term, given the stock's downtrend and execution risks. The most critical tension is whether Centrus can successfully scale HALEU production and replace Russian supply before its cash burn and debt burden become unsustainable. If execution succeeds, the stock could re-rate significantly; if not, it faces further downside.
Bullish
- Strategic HALEU Monopoly: Centrus is the only U.S.-owned and operated producer of HALEU, a critical fuel for advanced reactors. This monopoly position is reinforced by a $900 million government contract, providing a unique competitive moat and long-term revenue visibility.
- Record $3.9B Backlog: The company's record backlog of $3.9 billion, including a long-term fuel supply agreement with Oklo, secures future revenue streams. This backlog, combined with the recent Oklo deal, demonstrates strong demand for its nuclear fuel products.
- Analyst Consensus Buy: With 16 analysts, the consensus rating is 'Buy' (mean 1.78), and the average price target of $253.25 implies a 45.6% upside from the current price of $173.89. This bullish sentiment is supported by 8 Buy ratings versus only 1 Sell.
- AI-Driven Nuclear Demand: The AI energy boom is driving unprecedented demand for nuclear power, creating structural uranium supply deficits. Centrus is well-positioned to benefit from this secular tailwind, as highlighted in recent news and industry analyses.
Bearish
- Severe Stock Underperformance: LEU has declined 12.6% over the past year, while the S&P 500 gained 18.7%, resulting in a relative underperformance of over 31 percentage points. The stock is down 36.2% YTD and sits 62.5% below its 52-week high of $464.25, reflecting persistent selling pressure.
- High Valuation with Low Margins: The trailing PE of 56.1x and forward PE of 45.5x are elevated, especially given a gross margin of only 26.2% and operating margin of 11.2%. The market is pricing in significant growth, but any miss could lead to multiple compression.
- Revenue Volatility and Execution Risk: Quarterly revenue has swung from $154.5M in Q2 2025 to $74.9M in Q3 2025, reflecting the lumpy nature of uranium contracts. This volatility complicates forecasting and raises execution risk, particularly as the company scales HALEU production.
- Russian Contract Expiration: The expiration of a key Russian contract poses a significant risk to supply and revenue. Analysts have flagged this as a major overhang, and the low analyst target of $180 (only 3.5% above current price) reflects concerns about this dependency.
LEU Technical Analysis
Centrus Energy is in a pronounced downtrend over the past year, with the stock price declining 12.6% over the last 12 months, significantly underperforming the S&P 500's +18.7% gain. The current price of $173.89 sits at only 11.5% above the 52-week low of $142.13 and 62.5% below the 52-week high of $464.25, indicating the stock is trading near the bottom of its range. This positioning suggests a potential value opportunity, but also reflects persistent selling pressure and a lack of momentum, as the stock has been unable to reclaim higher levels despite occasional bounces.
Beta
1.33
1.33x market volatility
Max Drawdown
-66.4%
Largest decline past year
52-Week Range
$142-$464
Price range past year
Annual Return
-12.6%
Cumulative gain past year
| Period | LEU Return | S&P 500 |
|---|---|---|
| 1m | -7.3% | -0.4% |
| 3m | +7.5% | +4.5% |
| 6m | -7.9% | +13.9% |
| 1y | -12.6% | +19.0% |
| ytd | -36.2% | +12.9% |
Bobby - Your AI Investment Partner
Get real-time data, AI-driven personalized investment analysis to make smarter investment decisions
LEU Fundamental Analysis
Centrus Energy's revenue trajectory has been volatile, with the most recent quarter (Q1 2026) showing revenue of $76.7 million, a modest 4.9% year-over-year increase, but down significantly from the $146.2 million reported in Q4 2025. The multi-quarter trend reveals erratic performance: Q2 2025 revenue was $154.5 million, Q3 2025 dropped to $74.9 million, and Q4 2025 rebounded to $146.2 million, reflecting the lumpy nature of uranium sales contracts. The LEU segment, which includes separative work units (SWU) and uranium, remains the primary revenue driver, with SWU sales of $41.6 million and uranium sales of $3.0 million in the latest quarter, while the Technical Solutions segment contributed $32.1 million in service revenue. This volatility makes it challenging to assess a clear growth trajectory, but the company's record $3.9 billion backlog suggests future revenue visibility, though timing of deliveries remains uncertain.
Quarterly Revenue
$76700000.0B
2026-03
Revenue YoY Growth
+4.9%
YoY Comparison
Gross Margin
38.7%
Latest Quarter
Free Cash Flow
$-61400000.0B
Last 12 Months
Revenue & Net Income Trends (2 Years)
Revenue Breakdown
Open an Account, get $2 TSLA now!
Valuation Analysis: Is LEU Overvalued?
Given that Centrus Energy is profitable with a trailing net income of $10 million, the PE ratio is the most appropriate valuation metric. The trailing PE stands at 56.1x, while the forward PE is 45.5x, indicating that the market expects earnings growth of approximately 23% over the next year. This forward discount suggests optimism about future profitability, but the absolute levels are elevated, reflecting the market's pricing of significant growth expectations. The company's gross margin of 26.2% and operating margin of 11.2% are relatively low for a technology-driven nuclear fuel supplier, but the net margin of 17.3% benefits from non-operating income, which may not be sustainable.
PE
56.1x
Latest Quarter
vs. Historical
High-End
5-Year PE Range 1x~28x
vs. Industry Avg
N/A
Industry PE ~N/A*
EV/EBITDA
33.0x
Enterprise Value Multiple
Investment Risk Disclosure
Financial and operational risks are substantial. The company's debt-to-equity ratio of 1.59 indicates significant leverage, and its trailing free cash flow is negative at -$61.4 million, raising concerns about its ability to fund expansion without additional debt or dilution. Revenue is highly volatile, swinging from $154.5 million in Q2 2025 to $74.9 million in Q3 2025, reflecting lumpy contract deliveries. Gross margins are thin at 26.2%, and the operating margin of 11.2% leaves little room for error. The reliance on non-operating income for net profitability (net margin of 17.3%) is not sustainable, as it masks underlying operational weakness.
FAQ
The key risks include: 1) Financial risk: high debt-to-equity of 1.59 and negative free cash flow of -$61.4M, which could lead to liquidity issues or dilution. 2) Execution risk: delays in HALEU production or failure to secure alternative uranium supply after the Russian contract expires. 3) Market risk: high beta of 1.334 makes the stock sensitive to market downturns, and its premium valuation could lead to sharp declines if growth expectations are not met. 4) Competitive risk: international enrichers like Urenco and Orano could erode market share. The most severe risk is the Russian contract expiration, which could significantly impact revenue.
The 12-month forecast is mixed. In the bull case (25% probability), the stock could reach $250-$340, driven by successful HALEU execution and strong demand. In the base case (50% probability), the stock is expected to trade in the $200-$250 range, aligning with the analyst average target of $253.25. In the bear case (25% probability), the stock could fall to $142-$180, if execution fails or the Russian contract is not replaced. The most likely scenario is the base case, assuming moderate growth and continued backlog conversion.
LEU is overvalued relative to its current fundamentals. The trailing PE of 56.1x and forward PE of 45.5x are significantly higher than the industry average of around 20x. The PS ratio of 9.72x also indicates a premium valuation. However, the market is pricing in substantial growth due to the company's monopoly in HALEU and record backlog. If the company executes successfully, the valuation could be justified, but any disappointment could lead to multiple compression. Compared to its own history, the stock is trading below its 52-week high of $464.25, but still above its 52-week low of $142.13.
LEU is a high-risk, high-reward stock. The analyst consensus is 'Buy' with an average target of $253.25, implying 45.6% upside from the current price of $173.89. However, the stock has underperformed the market significantly, and its high valuation (forward PE of 45.5x) and negative free cash flow (-$61.4M) pose risks. It could be a good buy for investors with a high risk tolerance who believe in the nuclear energy boom and Centrus's strategic position in HALEU. For more conservative investors, it may be better to wait for a pullback or evidence of improved execution.
LEU is more suitable for long-term investment, given its strategic position in the nuclear fuel cycle and the multi-year nature of its contracts. The stock is highly volatile (beta of 1.334) and has a negative short-term momentum, making it risky for short-term trading. The company's growth story is tied to the development of advanced nuclear reactors, which will take years to materialize. Therefore, a minimum holding period of 3-5 years is recommended to allow the HALEU market to develop and for the company to execute its backlog. Short-term investors may find better opportunities elsewhere due to the stock's high volatility and uncertainty.
